Alkermes' Alcohol Dependence Drug Vivitrex On File With FDA April 4, 2005 By Aaron Lorenzo Alkermes Inc. applied for FDA approval of Vivitrex (naltrexone long-acting injection) to treat alcoholism, making it the first injectable product filed for the indication. (BioWorld Today)Read More
RSS